Compare

Beanstalks
vs Apollo

Apollo is a capable generalist B2B tool. Beanstalks is a biotech specialist. Heres why the specialist wins every email for life sciences.

Feature-by-feature

Based on publicly available information as of 2026.

Capability
Beanstalks
Apollo

Built exclusively for life sciences

Researcher-level data

Apollo is contact-level, not researcher-level

Pub / grant / h-index context

Live scientific API sources

4 (OpenAlex, PubMed, NIH, CT.gov)

Contact-level B2B coverage

Apollo strength

AI email personalization

Per-lead, paper-citing
Template-based

Native email sequences + sending

Native mailbox warmup

LinkedIn browser extension

Territory by institution type + topic

Starting price

$79/mo
$49-99/mo
Yes
Partial / Limited
No

Researcher profile

High fit
MK

Dr. Miriam Kessler

Broad Institute · Cell therapy · Boston, MA

h-index

42

Works

187

Grants

3

CAR-T persistence in solid tumors — Aug 2026
Single-cell signatures of T-cell exhaustion
R01 CA-263841 · $2.1M active
cell therapyimmunologyoncology

The core disagreement

Biotech sales is not B2B SaaS sales with lab coats.

Apollo treats every seller the same: B2B contact data, email sequences, LinkedIn integration. For selling to SaaS VPs, its a capable tool. For selling to a PI running CAR-T research, its wrong-sized data and wrong-shaped personalization. The contact record has no publications, no grants, no h-index, no research context. You can't cite the paper because there is no paper in the system.

  • Apollo's contact has: name, title, email, company, LinkedIn, company size
  • Beanstalks' contact has: all of that, plus h-index, last 5 papers, grants, topics
  • Personalization depth matches what your data has

Email preview

AI draft
To:m.kessler@broadinstitute.org
Subject:Your August paper on CAR-T persistence

Hi Miriam,

I read your August paper on CAR-T persistence in solid tumors — the single-cell signatures you identified match a use case our customers at MSK have run this year.

Would a 20-minute call next week make sense...

Cites paper from OpenAlex · Proof from your knowledge base

Personalization that matters

'Hi {firstName}' vs 'I saw your August paper on CAR-T persistence.'

The difference isn't the tool, it's the data. Apollo can run a beautiful sequence with first-name tokens and dynamic company names. Beanstalks writes emails that cite the specific paper your prospect published two months ago, because that paper is in the record.

  • Apollo: template + firstName + companyName substitution
  • Beanstalks: per-email generation citing real publication data
  • Read side-by-side: biotech PIs tell us one reads like a mail merge, the other like a colleague

Lead discovery

500K+ indexed
PIs publishing CAR-T · h-index > 25 · US only
AcademicPI / Lab headActive grantNortheast
MK

Miriam Kessler

Broad Institute · h-index 42

94

fit

DP

David Park

MSK Cancer Center · h-index 37

89

fit

AR

Anika Rao

Genentech · h-index 28

82

fit

JO

Jaime Ortega

UCSF · h-index 31

78

fit

When Apollo is still the right answer

If you are also selling to tech, use Apollo.

If your company sells to both biotech AND SaaS/tech/financial services, a generalist like Apollo covers more of your motion. If biotech is 100% of your revenue, the specialist wins on every send. The question is how much of your ICP overlaps with pure-science buyers.

  • Choose Apollo if: mixed ICP spanning biotech + non-biotech B2B
  • Choose Beanstalks if: 100% life sciences focus, want scientific data depth
  • Evaluating both: run a controlled test on your top 100 biotech prospects

Ready to grow your pipeline?

Start your 14-day free trial. No credit card required.

Start Free Trial